+
Site Tour

N. Van Mieghen "Navitor™ is a device iteration that really has changed the way we do our implantation"

Discover what N. Van Mieghem, M. Van Wely, L. Testa, M. Taramasso and M. Mullen think about Navitor™ stable delivery

Related Videos

Now you've got Navitor.
Future ready.

Now you've got Navitor. Remarkable performance.

Navitor™: Voice of the Experts Dave Smith

PCRLV 2021: MR & TR Clip Therapies

PremiClose 2024: Beside PDA closure

TAVI Summit - Cardiac imaging

PCRLV 2021: Transcatheter mitral valve replacement

PremiClose 2024: Neo-Ped Cardio Team

PCR London Valves 2022 – Tricuspid valve intervention

Navitor™: Hemodynamics

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platfrom

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Webinar PFO closure in patients >60 Years

Webinar PFO closure with Amplatzer™ Talisman™ PFO Occluder in patients >60 years

CONNEXT


HUB
RELATED RESOURCES

AVP III Case compendium

EuroEcho 2021: bRIGHT Gap Analysis

PCR LV 2021: Navitor™ 30-day outcomes

EuroEcho 2021: MR Treatment (Evidence)

CONNEXT


LIVE
RELATED EVENTS

EuroPCR 2023: Defining the future

Now you've got Navitor. Remarkable performance.

TAVI Summit - TAVR in bicuspid

TAVI Summit 2023: AS with HF

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline